济民可信研究院研发科学家在预印本网站bioRxiv发表文章称,正处于临床I期的新冠中和抗体JMB2002注射液对包括南非变异株(B.1.351)在内的多种新冠毒株具有体外阻断活性。文章题目为《A human antibody with blocking activity to RBD proteins of multiple SARS-CoV-2 variants including B.1.351 showed potent prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus macaques》。
点击链接查看更多:https://mp.weixin.qq.com/s/6AEe9eaWfKQkLClwpQa_5g